RE:RE:its appears the halt was just another ill advised pumpAgreed. Additionally, the fact is, we're talking about it. People are seeing this development unfold. The halt brought greater attention to it. Potential revenues from secured government contracts should certainly not be discounted. We've got a vertical here with many roads. The licensing deals are invaluable. The medical breakthroughs immeasurable. The applications only limited by the imagination of those steering the ship. In my opinion as a shareholder, the only uncertainty is: how many shares are enough?